FRI0495 Magnetic resonance imaging may be helpful in predicting long term efficacy of certolizumab pegol in patients with active rheumatoid arthritis

Abstract

BackgroundCertolizumab pegol (CZP) significantly improved signs and symptoms of RA in a diverse group of patients, including 37.6% who previously used a TNF inhibitor.1ObjectivesTo evaluate short-term non-contrast low-field MRI for...